SLC6A3 and Alzheimer disease: In line with this, in the present work we found a significant association between CSF DAT levels and both glucose metabolism of the SN, starting hub of the nigro-striatal pathway, and of the PCC, key hub of the DMN with an early and specific vulnerability in AD pathology.